This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Advances in development and application of human organoids
3 Biotech Open Access 08 May 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Monteil, V. et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell https://doi.org/10.1016/j.cell.2020.04.004 (2020), pre-proof available at https://www.cell.com/pb-assets/products/coronavirus/CELL_CELL-D-20-00739.pdf
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Allison, S.J. SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2. Nat Rev Nephrol 16, 316 (2020). https://doi.org/10.1038/s41581-020-0291-8
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41581-020-0291-8
This article is cited by
-
Coronavirus biology and replication: implications for SARS-CoV-2
Nature Reviews Microbiology (2021)
-
COVID-19 und Nierenbefall
Der Nephrologe (2021)
-
COVID-19 effects on the kidney
Der Pathologe (2021)
-
COVID-19-Auswirkungen auf die Niere
Der Pathologe (2021)
-
Advances in development and application of human organoids
3 Biotech (2021)